Fundraising Fox
/Companies
Sign in

Vitruviae

Nutley, US · 1 known investors

Find your way into Vitruviae

Each arrow is one introduction. Sign up to fill in the first one.

298 people can intro you to Mahiuddin

Ask Neil Nag to introduce you to Mahiuddin Ahmed

You →Neil · together at Memorial Sloan Kettering Cancer Center →Mahiuddin

65 people can intro you to Sonia

Ask Jamie Chen to introduce you to Sonia Sequeira

You →Jamie · together at Memorial Sloan-Kettering Cancer Center →Sonia

Sign up to find every way you can get introduced to Vitruviae

  • Your email: who you already know at Vitruviae, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vitruviae team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.

BiotechDeep TechHealthtech

Founders & leadership

SS
Sonia SequeiraChief Executive Officer (CEO), founderShe previously served as VP of Translational Science and Early Clinical Development at Y-mAbs Therapeutics and spent a decade leading product development at Memorial Sloan Kettering Cancer Center. She also holds the role of Chief Translational and Regulatory Officer at pHLIP Inc.
MA
Mahiuddin AhmedPresident and Chief Scientific Officer (CSO)He was previously SVP and Chief Scientific Officer at Y-mAbs Therapeutics, and before that spent nearly a decade at Memorial Sloan Kettering Cancer Center, advancing from research fellow to senior research scientist and assistant member.

Investors · 1

Frequently asked questions

What does Vitruviae do?
VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.
Who founded Vitruviae?
Vitruviae was founded by Sonia Sequeira.
Who are Vitruviae's investors?
Vitruviae's investors include Angel Physicians Fund.
Where is Vitruviae headquartered?
Vitruviae is headquartered in Nutley, US.